Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05865431 · ClinicalTrials.gov registry record · NA

Singlet Oxygen Quantification After Skin Exposure to Ultraviolet A (UVA) Light

A NA study of Sun Damaged Skin, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
17
Enrollment target
1
Study location

NCT05865431: Completed NA study of Sun Damaged Skin, sponsored by University of California, Davis.

NCT05865431 is a NA study of Sun Damaged Skin that has completed, run by University of California, Davis. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05865431, a NA study of Sun Damaged Skin, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is quantification of singlet oxygen species in the skin after exposure to Ultraviolet A (UVA) light

Conditions Studied

Interventions

  • DRUG Zinc Oxide and Avobenzone

Study Locations (1)

California

  • University of California, Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2017-03-17
Est. Completion 2018-02-02
Phase NA
University of California, Davis

657 total trials

What the finished NCT05865431 record still lists

NCT05865431 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Sun Damaged Skin appearing as the primary indexed condition, and to 1 intervention - of which Zinc Oxide and Avobenzone is the first listed.

NCT05865431 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05865431 about?

NCT05865431 is a clinical study titled "Singlet Oxygen Quantification After Skin Exposure to Ultraviolet A (UVA) Light". The objective of this study is quantification of singlet oxygen species in the skin after exposure to Ultraviolet A (UVA) light

What is the current status of trial NCT05865431?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2017-03-17. Estimated completion is 2018-02-02.

What conditions does trial NCT05865431 study?

This clinical trial studies the following conditions: Sun Damaged Skin.

What interventions are being tested in trial NCT05865431?

The interventions under investigation include: Zinc Oxide and Avobenzone (DRUG).

Who is sponsoring clinical trial NCT05865431?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05865431 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sun Damaged Skin

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05865431's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05865431, the US trial registry maintained by the National Library of Medicine. NCT05865431 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.